Roche Chair in Molecular Targeted Cancer Therapy

Faculteit

Geneeskunde

Schenker

Roche

Datum ondertekening

15 januari 2008

Duur

3 years

Doelstelling

The amount which the Sponsor puts at the disposal of K.U.Leuven will be used to help cover the teaching and/or research expenses of the holder of the Chair and to give the necessary publicity to the activities carried out in the framework of the Chair.

Titularis aan de K.U. Leuven

Prof. dr. Johan Vansteenkinste